Variables | HIV− n (%) | HIV+ n (%) | Total |
Hb | |||
≤10 g/dL | 1 (7.1%) | 0 (0.0%) | 1 (7.1%) |
>10 - 13 g/dL | 7 (50.0%) | 6 (42.9%) | 13 (46.4%) |
>13 g/dL | 6 (42.9%) | 8 (57.1%) | 14 (50.0%) |
Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
WBC | |||
<4000 elts/mm3 | 6 (42.9%) | 3 (21.4%) | 9 (32.1%) |
4000 - 10,000 elts/mm3 | 8 (57.1%) | 11 (78.6%) | 19 (67.9%) |
Total | 14 (100%) | 14 (100%) | 28 (100%) |
WBC differential | |||
Predominantly lymphocytic | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
CRP | |||
0 - 6 mg/dL | 13 (92.9%) | 12 (85.7%) | 25 (89.3%) |
>6 mg/dL | 1 (7.1%) | 2 (14.3%) | 3 (10.7%) |
Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
GOT | |||
0 - 31 UI/L | 12 (85.7%) | 10 (71.4%) | 22 (78.6%) |
>31 UI/L | 2 (14.3%) | 4 (28.6%) | 6 (21.4%) |
Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
GPT | |||
0 - 41 UI/L | 13 (92.9%) | 13 (92.9%) | 26 (92.9%) |
>41 UI/L | 1 (7.1%) | 1 (7.1%) | 2 (7.1%) |
Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
HDL | |||
<30 mg/dL | 1 (7.1%) | 2 (14.3%) | 3 (10.7%) |
30 - 60 mg/dL | 10 (71.4%) | 11 (78.6%) | 21 (75.0%) |
>60 mg/Dl | 3 (21.4%) | 1 (7.1%) | 4 (14.3%) |
Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
LDL | |||
<160 mg/dL | 12 (85.7%) | 13 (92.9%) | 25 (89.3%) |
>160 mg/dL | 2 (14.3%) | 1 (7.1%) | 3 (10.7%) |
Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |
TOTAL PROTEINS | |||
<6.6 g/dL | 2 (14.3%) | 1 (7.1%) | 3 (10.7%) |
6.6 - 8.2 g/dL | 11 (78.6%) | 13 (92.9%) | 24 (85.7%) |
>8.2 g/dL | 1 (7.1%) | 0 (0.0%) | 1 (3.6%) |
Total | 14 (100.0%) | 14 (100.0%) | 28 (100.0%) |